- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00919477
Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mg (CAMON)
January 21, 2013 updated by: AstraZeneca
To gather information on the safety of monotherapy of Casodex® tablets 80 mg, targeting prostate cancer patients who have no history of having received treatment by either endocrine therapy (including surgical castration).
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
712
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Aichi, Japan
- Research Site
-
Akita, Japan
- Research Site
-
Fukuoka, Japan
- Research Site
-
Fukushima, Japan
- Research Site
-
Gifu, Japan
- Research Site
-
Hiroshima, Japan
- Research Site
-
Kochi, Japan
- Research Site
-
Kumamoto, Japan
- Research Site
-
Kyoto, Japan
- Research Site
-
Nagasaki, Japan
- Research Site
-
Nara, Japan
- Research Site
-
Okayama, Japan
- Research Site
-
Osaka, Japan
- Research Site
-
Saitama, Japan
- Research Site
-
Shizuoka, Japan
- Research Site
-
Tokushima, Japan
- Research Site
-
Tottori, Japan
- Research Site
-
Toyama, Japan
- Research Site
-
Wakayama, Japan
- Research Site
-
Yamagata, Japan
- Research Site
-
-
Aichi
-
Houmei, Aichi, Japan
- Research Site
-
Inuyama, Aichi, Japan
- Research Site
-
Kasugai, Aichi, Japan
- Research Site
-
Nagoya, Aichi, Japan
- Research Site
-
Okazaki, Aichi, Japan
- Research Site
-
Toyohashi, Aichi, Japan
- Research Site
-
Toyota, Aichi, Japan
- Research Site
-
-
Akita
-
Odate, Akita, Japan
- Research Site
-
-
Aomori
-
Hirosaki, Aomori, Japan
- Research Site
-
-
Chiba
-
Asahi, Chiba, Japan
- Research Site
-
Funahashi, Chiba, Japan
- Research Site
-
Ichihara, Chiba, Japan
- Research Site
-
Ichikawa, Chiba, Japan
- Research Site
-
Narashino, Chiba, Japan
- Research Site
-
Sakura, Chiba, Japan
- Research Site
-
-
Ehime
-
Imabari, Ehime, Japan
- Research Site
-
Matsuyama, Ehime, Japan
- Research Site
-
Niihama, Ehime, Japan
- Research Site
-
Uwajima, Ehime, Japan
- Research Site
-
-
Fukuoka
-
Chikushino, Fukuoka, Japan
- Research Site
-
Iizuka, Fukuoka, Japan
- Research Site
-
Kasuga, Fukuoka, Japan
- Research Site
-
Kita Kyushu, Fukuoka, Japan
- Research Site
-
Kurume, Fukuoka, Japan
- Research Site
-
Yukuhashi, Fukuoka, Japan
- Research Site
-
-
Fukushima
-
Aizuwakamatsu, Fukushima, Japan
- Research Site
-
-
Gifu
-
Ibi, Gifu, Japan
- Research Site
-
Kani, Gifu, Japan
- Research Site
-
Minokamo, Gifu, Japan
- Research Site
-
Mizunami, Gifu, Japan
- Research Site
-
Ogaki, Gifu, Japan
- Research Site
-
Seki, Gifu, Japan
- Research Site
-
Yamagata, Gifu, Japan
- Research Site
-
Yourou, Gifu, Japan
- Research Site
-
-
Gunma
-
Isesaki, Gunma, Japan
- Research Site
-
Kiryu, Gunma, Japan
- Research Site
-
Numata, Gunma, Japan
- Research Site
-
Ohta, Gunma, Japan
- Research Site
-
Takasaki, Gunma, Japan
- Research Site
-
-
Hokkaido
-
Asahikawa, Hokkaido, Japan
- Research Site
-
Eniwa, Hokkaido, Japan
- Research Site
-
Kushiro, Hokkaido, Japan
- Research Site
-
Sapporo, Hokkaido, Japan
- Research Site
-
Sunagawa, Hokkaido, Japan
- Research Site
-
Tomakomai, Hokkaido, Japan
- Research Site
-
-
Hyogo
-
Akashi, Hyogo, Japan
- Research Site
-
Katou, Hyogo, Japan
- Research Site
-
Kobe, Hyogo, Japan
- Research Site
-
Takarazuka, Hyogo, Japan
- Research Site
-
-
Ibaraki
-
Hitachi, Ibaraki, Japan
- Research Site
-
Mito, Ibaraki, Japan
- Research Site
-
Sashima, Ibaraki, Japan
- Research Site
-
Toride, Ibaraki, Japan
- Research Site
-
Tsuchiura, Ibaraki, Japan
- Research Site
-
-
Ishihawa
-
Hakusan, Ishihawa, Japan
- Research Site
-
-
Iwate
-
Ichinoseki, Iwate, Japan
- Research Site
-
Kamaishi, Iwate, Japan
- Research Site
-
Miyako, Iwate, Japan
- Research Site
-
Morioka, Iwate, Japan
- Research Site
-
Shiwa, Iwate, Japan
- Research Site
-
-
Kagawa
-
Takamatsu, Kagawa, Japan
- Research Site
-
Zentrsuji, Kagawa, Japan
- Research Site
-
-
Kagoshima
-
Minami Satsuma, Kagoshima, Japan
- Research Site
-
-
Kanagawa
-
Atsugi, Kanagawa, Japan
- Research Site
-
Chigasaki, Kanagawa, Japan
- Research Site
-
Ebina, Kanagawa, Japan
- Research Site
-
Kawasaki, Kanagawa, Japan
- Research Site
-
Sagamihara, Kanagawa, Japan
- Research Site
-
Yamato, Kanagawa, Japan
- Research Site
-
Yokohama, Kanagawa, Japan
- Research Site
-
Yokosuka, Kanagawa, Japan
- Research Site
-
-
Kyoto
-
Nantan, Kyoto, Japan
- Research Site
-
-
Mie
-
Inabe, Mie, Japan
- Research Site
-
Tsu, Mie, Japan
- Research Site
-
-
Miyagi
-
Matsushima, Miyagi, Japan
- Research Site
-
Natori, Miyagi, Japan
- Research Site
-
Sendai, Miyagi, Japan
- Research Site
-
Shiogama, Miyagi, Japan
- Research Site
-
Tagajo, Miyagi, Japan
- Research Site
-
-
Nagasaki
-
Isahaya, Nagasaki, Japan
- Research Site
-
Sasebo, Nagasaki, Japan
- Research Site
-
-
Nara
-
Ikoma, Nara, Japan
- Research Site
-
Kashiba, Nara, Japan
- Research Site
-
-
Niigata
-
Gosen, Niigata, Japan
- Research Site
-
Tsubame, Niigata, Japan
- Research Site
-
-
Oita
-
Nakatsu, Oita, Japan
- Research Site
-
-
Okayama
-
Kurashiki, Okayama, Japan
- Research Site
-
-
Osaka
-
Habikino, Osaka, Japan
- Research Site
-
Ibaraki, Osaka, Japan
- Research Site
-
Ikeda, Osaka, Japan
- Research Site
-
Izumisano, Osaka, Japan
- Research Site
-
Kaizuka, Osaka, Japan
- Research Site
-
Kishiwada, Osaka, Japan
- Research Site
-
Matsubara, Osaka, Japan
- Research Site
-
Minoo, Osaka, Japan
- Research Site
-
Motiguchi, Osaka, Japan
- Research Site
-
Neyagawa, Osaka, Japan
- Research Site
-
Osaka Sayama, Osaka, Japan
- Research Site
-
Sakai, Osaka, Japan
- Research Site
-
Suita, Osaka, Japan
- Research Site
-
Toyonaka, Osaka, Japan
- Research Site
-
Yao, Osaka, Japan
- Research Site
-
-
Saitama
-
Asagiri, Saitama, Japan
- Research Site
-
Hidaka, Saitama, Japan
- Research Site
-
Kawagoe, Saitama, Japan
- Research Site
-
Koshigaya, Saitama, Japan
- Research Site
-
Kumagaya, Saitama, Japan
- Research Site
-
Sayama, Saitama, Japan
- Research Site
-
-
Shimane
-
Hamada, Shimane, Japan
- Research Site
-
-
Shizuoka
-
Fuji, Shizuoka, Japan
- Research Site
-
Fujieda, Shizuoka, Japan
- Research Site
-
Hamamatsu, Shizuoka, Japan
- Research Site
-
Izu, Shizuoka, Japan
- Research Site
-
Shimizu, Shizuoka, Japan
- Research Site
-
-
Tochigi
-
Ashikaga, Tochigi, Japan
- Research Site
-
-
Tokushima
-
Yoshinogawa, Tokushima, Japan
- Research Site
-
-
Tokyo
-
Adachi, Tokyo, Japan
- Research Site
-
Arakawa, Tokyo, Japan
- Research Site
-
Chiyoda, Tokyo, Japan
- Research Site
-
Edogawa, Tokyo, Japan
- Research Site
-
Itabashi, Tokyo, Japan
- Research Site
-
Katsushika, Tokyo, Japan
- Research Site
-
Koutou, Tokyo, Japan
- Research Site
-
Minato, Tokyo, Japan
- Research Site
-
Musashino, Tokyo, Japan
- Research Site
-
Nakano, Tokyo, Japan
- Research Site
-
Nishi Tokyo, Tokyo, Japan
- Research Site
-
Oota, Tokyo, Japan
- Research Site
-
Ota, Tokyo, Japan
- Research Site
-
Setagaya, Tokyo, Japan
- Research Site
-
Shibuya, Tokyo, Japan
- Research Site
-
Shinagawa, Tokyo, Japan
- Research Site
-
Shinjyuku, Tokyo, Japan
- Research Site
-
Sumida, Tokyo, Japan
- Research Site
-
Tachikawa, Tokyo, Japan
- Research Site
-
Toshima, Tokyo, Japan
- Research Site
-
-
Toyama
-
Kurobe, Toyama, Japan
- Research Site
-
Takaoka, Toyama, Japan
- Research Site
-
-
Yamagata
-
Kahoku, Yamagata, Japan
- Research Site
-
-
Yamanashi
-
Kai, Yamanashi, Japan
- Research Site
-
Nirasaki, Yamanashi, Japan
- Research Site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Sampling Method
Probability Sample
Study Population
Prostate cancer patients who have no history of having received treatment by either endocrine therapy (including surgical castration)
Description
Inclusion Criteria:
- Prostate cancer patients who have no history of receiving endocrine therapy (including surgical castration), and who plan to undergo Casodex® tablets monotherapy for not less than 12 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Adverse event incidence
Time Frame: Time since starting Casodex monotherapy, monthly
|
Time since starting Casodex monotherapy, monthly
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
improvement of prostate cancer using Tumor marker PSA
Time Frame: Time since starting Casodex monotherapy, monthly
|
Time since starting Casodex monotherapy, monthly
|
Maintenance of sexual function
Time Frame: At 3 months since starting Casodex monotherapy,
|
At 3 months since starting Casodex monotherapy,
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2009
Primary Completion (Actual)
March 1, 2012
Study Completion (Actual)
March 1, 2012
Study Registration Dates
First Submitted
June 11, 2009
First Submitted That Met QC Criteria
June 11, 2009
First Posted (Estimate)
June 12, 2009
Study Record Updates
Last Update Posted (Estimate)
January 23, 2013
Last Update Submitted That Met QC Criteria
January 21, 2013
Last Verified
January 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NIS-OJP-CAS-2009/1
- CAS002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostate Cancer
-
Roswell Park Cancer InstituteRecruitingObesity | Overweight | Cancer Survivor | Prostate Adenocarcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage A Prostate Cancer | Stage... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Regeneron Pharmaceuticals; Prostate Cancer FoundationWithdrawnStage III Prostate Cancer | Stage IV Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage IIIA Prostate Cancer | Stage IIIB Prostate Cancer | Stage IIIC Prostate Cancer
-
Jonsson Comprehensive Cancer CenterProgenics Pharmaceuticals, Inc.TerminatedRandomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer (PSMA-dRT)Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Stage I Prostate...United States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); SanofiTerminatedDiarrhea | Recurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Ryan Kohlbrenner, MDRadiological Society of North AmericaCompletedProstate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Prostate Carcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage...United States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate...United States
-
Barbara Ann Karmanos Cancer InstituteGenentech, Inc.CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Ohio State University Comprehensive Cancer CenterRiverside Methodist HospitalCompletedStage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
University of California, IrvineCompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States